The ROE as of June 2026 (TTM) for GT Biopharma, Inc. (GTBP) is -901.32%

According to GT Biopharma, Inc.’s latest financial reports and current stock price. The company's current ROE is -901.32%. This represents a change of 359.26% compared to the average of -196.26% of the last 4 quarters.

GT Biopharma, Inc. (GTBP) Historical ROE (quarterly & annually)

How has GTBP ROE performed in the past?

The mean historical ROE of GT Biopharma, Inc. over the last ten years is -230.31%. The current -901.32% ROE has changed 291.35% with respect to the historical average. Over the past ten years (40 quarters), GTBP's ROE was at its highest in in the September 2025 quarter at 276.63%. The ROE was at its lowest in in the September 2018 quarter at -1748.87%.

GT Biopharma, Inc. (GTBP) ROE by Quarter and Year

Discovering the peaks and valleys of GT Biopharma, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

GT Biopharma, Inc. (GTBP) Average ROE

How has GTBP ROE performed in the past?

The current ROE of GT Biopharma, Inc. (GTBP) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

GT Biopharma, Inc. (GTBP) ROE vs. Peers

How is GTBP’s ROE compared to its peers?

GT Biopharma, Inc.’s ROE is greater than Artelo Biosciences, Inc. (-1602.50%), less than Protagenic Therapeutics, Inc. (184.88%), greater than Carisma Therapeutics, Inc. (-28.86%), greater than Salarius Pharmaceuticals, Inc. (-395.42%), greater than Windtree Therapeutics, Inc. (-1302.82%), greater than Psyence Biomedical Ltd. (-47.61%), greater than Silexion Therapeutics Ltd. (-516.87%), greater than Lipella Pharmaceuticals Inc. (-208.44%), greater than Dermata Therapeutics, Inc. (-127.91%), greater than Revelation Biosciences, Inc. (-107.66%),

Build a custom stock screener for GT Biopharma, Inc. (GTBP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GT Biopharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

GT Biopharma, Inc. (GTBP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like GT Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.